Summary: To require the Secretary of Health and Human Services to establish a demonstration project to increase access to biosimilar biological products under the Medicare program. (Cosponsors)
ANGIE CRAIG’S POSITION: Representative Craig Cosponsored the bill on 03/10/20.
STATUS: Introduced 03/10/20 by Rep. Cardenas, Tony [D-CA-29].
INFORMATION RELATED TO THE BILL:
Biosimilar medicines are safe, effective and affordable versions of costly brand biologics for the treatment of cancer, rheumatoid arthritis and other complex diseases. Biosimilars are widely viewed as the next frontier for affordable medicines. By the year 2025, more than 70 percent of drug approvals are expected to be biological products. Experts estimate that biosimilars could save between $44 billion and $250 billion over the next 10 years. (Source: Association for Accessible Medicines)
Link to the text of the bill.
Link to bill information (support and opposition) on Countable.
Link to bill information on GovTrack.